Recall for Levomepromazin-Neuraxpharm Ampoules

HPS Pharmacies wish to give notice that Link Medical Products, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for Levomepromazin-Neuraxpharm Ampoules as follows:

Levomepromazin-Neuraxpharm Ampoules
Levomepromazine 25mg/1mL

The only batch affected by this drug recall is: 220731 (expiry 11/2026).

This drug recall was initiated due to overseas reports of brownish discolouration on individual ampoules, which indicates a quality problem. Please note that this product is not registered on the Australian Register of Therapeutic Goods (ARTG). It would only have been supplied via the Special Access Scheme (SAS).

Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Link Medical on (02) 8401 9788 or your pharmacist at HPS Pharmacies.

Download PDF